NSCLC responds to hypoxic microenvironments by downregulating YTHDF1, thereby inducing cisplatin resistance through the modulation of CDK2, CDK4, and cyclin D1 translation.138. The gene discussed is CDK4; the disease is non-small cell lung carcinoma.